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Periodontal disease is one of the leading
causes of tooth loss, particularly among
older individuals (1–6). Although den-
tal plaque-associated microorganisms are
the primary etiologic agents of periodon-
tal diseases, several other factors such as
local, genetic, systemic, and environmental
factors play an important role in deter-
mining the susceptibility of individuals to
periodontal diseases. Tobacco smoking is
one of the most important environmen-
tal risk factors for periodontal diseases.
Large numbers of studies have been con-
ducted to understand the role of smoking
in the etiology of periodontal diseases and
the available data show that smoking is
associated with increased prevalence and
severity of periodontal disease, which may
be due to the adverse effects of tobacco
smoke on the physiology, immunology,
and microbiology of the oral environment.
Unlike smoking, the role of oral smokeless
tobacco (SLT) in the etiology of periodon-
tal disease has received considerably less
attention.
Although traditionally, oral SLT con-
sumption has been associated with
oral malignant and potentially malignant
lesions, emerging data suggest that these
habits may be associated with poor peri-
odontal health also. Besides some case
reports mentioning periodontal changes
associated with oral SLT habits (7), initial
studies conducted in the US have shown
that oral SLT habits are associated with
increased incidence of gingival recession
(8–11). Studies conducted in Sweden also
have shown that the consumption of moist
snuff, an oral SLT product, is associated
with increased prevalence of gingival reces-
sion (12–14). However, some studies con-
ducted in the US and Sweden have failed to
show any association between SLT habits
and periodontal changes such as gingi-
val recession, attachment loss, or bone
loss (15–18). Unlike the studies among
the Swedish and US populations, stud-
ies conducted among Asian populations
have shown that oral SLT habits are associ-
ated with destructive periodontal disease.
Studies conducted in India have reported
that oral SLT users tend to have higher
scores and risk for periodontal disease (19–
22). Similar results were reported among
SLT users in Bangladesh and Thailand
also (23, 24). A study based on National
Health and Nutrition Examination Sur-
vey III data conducted in the US also
showed strong association between oral
SLT use and severe active periodontal dis-
ease (25).
Very few studies have reported on the
pattern of periodontal destruction among
oral SLT users. A study on the patterns of
tooth loss among tobacco users in central
India showed that mandibular tooth loss
was more among oral SLT users suggest-
ing that the deleterious effects of SLT use is
manifested more in mandibular teeth (26).
Studies reporting the occurrence of gingi-
val recession among oral SLT users have
reported that these occurred at sites adja-
cent to mucosal lesions suggesting that the
recession was a result of long-term injury
to the gingival tissues from the SLT product
(8, 10, 13, 14). Oral SLT users in a cen-
tral Indian population were shown to have
an increase in prevalence and severity of
recession and attachment loss at mandibu-
lar teeth, buccal surfaces, anterior teeth,
and molars-the surfaces most likely to
have prolonged exposure to SLT product
due to retention of the SLT product at
the mandibular buccal or anterior labial
vestibule (21).
Oral SLT consumption in various forms
is highly prevalent among all populations,
particularly in the Asian countries (27–
35), and a wide variety of SLT products
are available worldwide (36, 37). The most
common SLT products available in the US
include chewing tobacco and snuff (moist
and dry), and in Sweden, the most common
product is snus. In Asian countries, such
as India and Bangladesh, a myriad of SLT
products are available such as betel quid
with tobacco, zarda (prepared by boiling
tobacco leaves with water and slaked lime),
gutka (mixture of powdered tobacco, areca
nut, slaked lime, and catechu), mawa (areca
nut, tobacco, and slaked lime), and khaini
(tobacco with slaked lime).
Although oral SLT habits are common
among all populations, strong associations
between SLT habits and destructive peri-
odontal disease has been observed mainly
among Asian populations, whereas a sys-
tematic review of studies testing the asso-
ciation between SLT habits and periodon-
tal disease conducted in Sweden and the
US suggested that SLT habits may not be
related to periodontal diseases (38). Such
contradictory observations may be due to
several factors such as differences in the
trends of oral SLT practices and the type
of SLT products used by the respective
populations.
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While products such as the Swedish
snus has been shown to be less harm-
ful compared to smoking and other SLT
products (39), oral SLT products avail-
able commercially in India and other
Asian countries contain more than 4000
toxic ingredients, which can cause tissue
injury on account of their mutagenic and
carcinogenic properties (40, 41). These
include alkaloids such as nicotine, tobacco-
specific nitrosamines, phytosterols such
as cholesterol, heterocyclic hydrocarbons,
pesticides, alkali nitrites, radioactive sub-
stances, and toxic metals such as lead, cad-
mium, and arsenic (41). Moreover, among
Asian populations, unlike smoking, which
is almost exclusively confined to males,
oral SLT consumption is highly prevalent
among both males and females (32, 34,
42). The high prevalence of these habits
may be due to a general misconception,
particularly among Asian populations, that
oral SLT habits are generally less harm-
ful than smoking. While this may be true
of certain products such as the Swedish
snus, which is being recommended as a
less harmful alternative to smoking (39,
43, 44), the products available in the Asian
countries have been shown to contain large
quantities of chemicals, which are toxic to
the human tissues (40, 41). Moreover, such
habits are culturally ingrained among these
populations, which consider SLT products
as relatively acceptable forms of tobacco
consumption when compared to smok-
ing, and individuals, considering it as a
part of their life style, are introduced to
such habits at a very young age (32, 45,
46). Lower levels of education, poor socio-
economic status, and rural areas of res-
idence have also been identified as fac-
tors associated with oral SLT consumption
(31, 32, 42, 47, 48). Studies on tobacco-
cessation behavior have shown that oral
SLT users are less likely to attempt quit-
ting the habit compared to smokers in spite
of an awareness of the harmful effects of
such habits (49, 50). On account of these
variations in the products and patterns
of SLT consumption, comparison between
observations from Asian populations and
those from European and US populations
becomes difficult.
Another factor that needs to be consid-
ered while assessing the strength of asso-
ciation between SLT and periodontal dis-
ease is the fact that the SLT products used
in Asian countries, where a stronger evi-
dence of association is found, contains a
wide variety of ingredients besides tobacco
such as betel quid, areca nut, slaked lime,
catechu, spices, etc. Moreover, the meth-
ods of preparation of these products also
vary, which may contribute to alteration
of toxicity of these ingredients. Hence,
it may be difficult to identify the spe-
cific effects of tobacco on the periodon-
tal tissues. Furthermore, the effects of
these different commercial products on
the periodontal tissues may also be differ-
ent on account of their different chemical
composition. To the best of our knowl-
edge, no product-specific data regarding
the effect of SLT on periodontal health
among Indian or other Asian populations
is available.
Nicotine, the principal alkaloid in
tobacco, exerts a wide range of effects on
the immune system and wound healing,
which may play an important role in peri-
odontal tissue destruction (51). Nicotine
exposure has been shown to result in vaso-
constriction (52, 53) and impaired angio-
genesis (54, 55). Its effects on neutrophil
function include increased shedding of
adhesion molecules (56) and alteration of
f-actin kinetics (57), resulting in reduced
migration of neutrophils into the oral tis-
sues (58), and inhibition of phagocyto-
sis and oxidative killing (59, 60). Nicotine
exposure also results in reduced prolifera-
tion and function of T-lymphocytes (61),
decreased phagocytosis and production of
pro-inflammatory cytokines and oxygen
radicals by monocytes (59, 62), increased
levels of tissue-destructive cytokine such as
TNF-α (63), reduction in levels of antibod-
ies to periodontal pathogens (64–67), and
impaired attachment of human periodon-
tal ligament fibroblasts (68).
Absorption of nicotine from SLT prod-
ucts occurs through the oral mucosa and
absorption is higher from products, which
have a higher pH (41, 69, 70). SLT prod-
ucts from different countries differ in their
values of pH, total nicotine, and unionized
nicotine, with products available in south-
east Asian countries having higher levels of
these parameters (37). On account of these
differences, there are considerable limita-
tions in drawing broad conclusions on the
impact of SLT products on public health.
Nevertheless, considering the health
hazards posed by oral SLT habits, par-
ticularly among Asian populations, and
the high prevalence of such habits among
both males and females, lack of willingness
among SLT users to quit the habit is alarm-
ing, particularly since nicotine depen-
dence and withdrawal symptoms have been
shown to be higher among oral SLT users
than smokers (71). In the context of such
widespread use of SLT products, the impli-
cations of the effects of such habits on peri-
odontal and oral health and on oral health-
related quality of life cannot be ignored. In
populations, where the tobacco consump-
tion in the form of oral SLT products is
predominant compared to smoking, the
role of oral SLT products on periodontal
health should be considered in the etiology
of periodontal diseases. The possible role
of oral SLT habits in the etiology of peri-
odontal disease among these populations
has important implications not only for
future research but also for design of public
health programs as well as for periodontal
treatment planning.
Further studies need to be carried out
in high-risk populations with improved
methodology and incorporating additional
parameters such as type of SLT product
used, alveolar bone level, and microbial fac-
tors to better understand the relationship
between oral SLT habits and periodon-
tal diseases. Knowledge generated from
such research endeavors can be combined
with the data generated from epidemio-
logic studies regarding factors contributing
to the initiation and maintenance of oral
SLT habits so as to design public health
programs for tackling the burden of SLT
habits. SLT-cessation programs in dental
settings have been shown to be effective
in increasing the proportion of oral SLT
users who quit the habit (72, 73). Hence,
tobacco-cessation programs in a dental set-
ting should also include smokeless forms.
Once such modifications are successfully
implemented, the periodontist can play a
greater role in tackling this social menace of
SLT consumption, thereby contributing to
a reduction in the economic burden arising
from these habits as well as an improve-
ment of oral and general health and related
quality of life.
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